Showing results (351-360 of 402) with videos related to
Sort By:
Pageof 41
Acta Haematologica|October 8, 2019
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular ManagementSusanne Saussele, Wilhelm Haverkamp, Fabian Lang, et al.Leukemia Research|September 24, 2020
Prevalence and characteristics of myeloproliferative neoplasms with concomitant monoclonal gammopathyNora Rebeka Javorniczky, Julius Wehrle, Gabriele Ihorst, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 6, 2015
Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)J Vansteenkiste, F Barlesi, C F Waller, et al.Journal of Cell Science|June 6, 2020
Real-time dynamics of Plasmodium NDC80 reveals unusual modes of chromosome segregation during parasite proliferationMohammad Zeeshan, Rajan Pandey, David J P Ferguson, et al.International Journal of Radiation Oncology, Biology, Physics|March 7, 2025
Impact of Different Mediastinal Staging Modalities on Target Volume Delineation in Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of the Multicenter Randomized PET-Plan TrialAndreas Rimner, Cas Stefaan Dejonckheere, Jörg Sahlmann, et al.Haematologica|June 2, 2016
Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trialHaifa Kathrin Al-Ali, Martin Griesshammer, Philipp le Coutre, et al.International Journal of Cancer|March 24, 2026
Prediction of the individual risk for the development of brain metastases in patients with non-oncogene-addicted non-small cell lung cancer: Real-world data from the German prospective CRISP registry (AIO-TRK-0315)Fabian Acker, Katharina Wenger, Martin Reck, et al.Annals of Hematology|March 3, 2019
Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropeniaCornelius F Waller, Gopinath M Ranganna, Eduardo J Pennella, et al.Nature Communications|April 15, 2023
Stable endocytic structures navigate the complex pellicle of apicomplexan parasitesLudek Koreny, Brandon N Mercado-Saavedra, Christen M Klinger, et al.Proceedings of the National Academy of Sciences of the United States of America|December 29, 2016
Major transitions in dinoflagellate evolution unveiled by phylotranscriptomicsJan Janouškovec, Gregory S Gavelis, Fabien Burki, et al.Pageof 41